Tech Company Financing Transactions
Zymvol Biomodeling Funding Round
Elaia Partners participated in a $1.4 million Seed funding round for Zymvol Biomodeling. This venture round closed on 2/21/2023.
Transaction Overview
Company Name
Announced On
2/21/2023
Transaction Type
Venture Equity
Amount
$1,380,000
Round
Seed
Investors
Elaia Partners (Lead Investor)
Proceeds Purpose
Barcelona-based Zymvol wants to spread enzymes. Everywhere. From the pharma industry to the chemical and food industries enzymes, and the discovery and widespread usage thereof is big business.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
C/ Pau Claris, 94, 3B
Barcelona, 08010
ES
Barcelona, 08010
ES
Phone
Website
Email Address
Overview
ZYMVOL BIOMODELING SL is a biotech company based in Barcelona, Spain, and specialized in the design, development and application of molecular modeling software to enzyme discovery and optimization. Founded in 2017 by the 3 co-founders and still privately owned, the company has grown into a multidisciplinary team of highly specialized experts with a strong track record in successful enzyme engineering, discovery and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Lucas
Browse more venture capital transactions:
Prev: 2/21/2023: Chronicle venture capital transaction
Next: 2/21/2023: Paleo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs